Desmopressin Impurity 14 is a related peptide species that forms during synthesis or degradation of desmopressin. Subtle sequence or protecting-group differences shift its chromatographic and spectrometric signatures. Researchers use it to validate analytical sensitivity and specificity. Applications include impurity profiling, peptide-process characterization, and structural-variant comparison.
CAT No: Z10-101-193
Desmopressin impurity 14 is a synthetic peptide derivative structurally related to desmopressin, a well-known vasopressin analog. As a defined impurity, it represents a specific byproduct or side product formed during the synthesis or degradation of desmopressin. Its characterization and availability are critical for researchers and manufacturers engaged in peptide analysis, pharmaceutical development, and quality assurance. The precise identification and study of such impurities provide valuable insights into the chemical stability, synthetic routes, and overall quality profile of peptide-based drug substances, making Desmopressin impurity 14 a significant reference compound in analytical and regulatory settings.
Analytical method development: In the context of pharmaceutical and peptide research, Desmopressin impurity 14 serves as an essential reference standard for the development and validation of analytical methods. Its inclusion enables scientists to accurately detect, separate, and quantify impurities within desmopressin bulk substances and finished products. Techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and capillary electrophoresis rely on well-characterized impurities to ensure specificity, sensitivity, and reproducibility in impurity profiling, which is fundamental for robust method validation and subsequent routine quality control.
Impurity profiling and characterization: The presence and quantification of Desmopressin impurity 14 are vital components of comprehensive impurity profiling studies. By comparing the retention time, mass spectra, and physicochemical properties of this impurity to those observed in production batches, researchers can gain a deeper understanding of the synthetic process, identify potential degradation pathways, and monitor batch-to-batch consistency. Such studies are essential for defining impurity limits, supporting regulatory submissions, and ensuring that peptide products meet rigorous quality standards.
Process optimization in peptide synthesis: The occurrence of Desmopressin impurity 14 during synthetic procedures provides valuable feedback for process chemists aiming to optimize peptide manufacturing. By monitoring the formation of this impurity under various reaction conditions, researchers can identify critical parameters affecting product purity and yield. This knowledge allows for targeted adjustments in reagents, solvents, or purification techniques, ultimately leading to more efficient, scalable, and reproducible synthetic protocols for desmopressin and related peptides.
Stability studies and forced degradation analysis: The use of Desmopressin impurity 14 as a reference compound is instrumental in conducting forced degradation and stability-indicating studies. By deliberately exposing desmopressin formulations to stress conditions such as heat, light, or oxidative environments, analysts can track the generation of specific impurities, including impurity 14. These experiments help elucidate degradation mechanisms, establish shelf-life parameters, and inform the development of appropriate storage and packaging solutions for peptide pharmaceuticals.
Regulatory compliance and quality assurance: In the context of regulatory submissions and ongoing quality assurance, the accurate identification and quantification of Desmopressin impurity 14 are crucial for demonstrating compliance with international guidelines on impurity control. Its use as a calibrated standard supports the preparation of impurity profiles required in drug master files, certificates of analysis, and other documentation. This ensures that manufacturers can provide transparent, scientifically robust evidence of product quality and safety throughout the lifecycle of desmopressin-based therapeutics and research reagents.
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More